Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies

키워드

참고문헌 (70)

1. Compston A, "Multiple sclerosis", Lancet, 359, pp.1221~1231 (2002)
2. de Sèze M, "The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines", Mult Scler, 13, pp.915~928 (2007)
3. Phé V, "Management of neurogenic bladder in patients with multiple sclerosis", Nat Rev Urol, 13, pp.275~288 (2016)
4. Mahajan ST, "Under treatment of overactive bladder symptoms in patients with multiple sclerosis : an ancillary analysis of the NARCOMS Patient Registry", J Urol, 183, pp.1432~1437 (2010)
5. Fowler CJ, "A UK consensus on the management of the bladder in multiple sclerosis", J Neurol Neurosurg Psychiatry, 80, pp.470~477 (2009)
6. Lemack GE, "Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis : analysis of risk factors at initial urologic evaluation", Urology, 65, pp.854~857 (2005)
7. Wein AJ, "Campbell-Walsh Urology", pp.1761~1795 (2016), Elsevier Mosby
8. Fowler CJ, "The neural control of micturition", Nat Rev Neurosci, 9, pp.453~466 (2008)
9. Araki I, "Relationship of bladder dysfunction to lesion site in multiple sclerosis", J Urol, 169, pp.1384~1387 (2003)
10. Weissbart SJ, "The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis", Neurourol Urodyn, 36, pp.453~456 (2017)
11. Amaro JL, "Effect of intravaginal electrical stimulation on pelvic floor muscle strength", Int Urogynecol J Pelvic Floor Dysfunct, 16, pp.355~358 (2005)
12. Schmidt EZ, "Sexuality in multiple sclerosis", J Neural Transm(Vienna), 112, pp.1201~1211 (2005)
13. Tepavcevic DK, "The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis", Mult Scler, 14, pp.1131~1136 (2008)
14. McClurg D, "Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study", Neurourol Urodyn, 25, pp.337~348 (2006)
15. Stöhrer M, "EAU guidelines on neurogenic lower urinary tract dysfunction", Eur Urol, 56, pp.81~88 (2009)
16. Zachariou A, "Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron", Can J Urol, 24, pp.9107~9113 (2017)
17. Krhut J, "Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study", Neurourol Urodyn, 37, pp.2226~2233 (2018)
18. Abo Youssef N, "Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis : a systematic review and meta-analysis", BJU Int, 119, pp.515~521 (2017)
19. Maniscalco GT, "THC", CBD oromucosal spray in patients with multiple sclerosis overactive bladder : a pilot prospective study, 2018, pp.39, 97~102
20. Gobbi C, "Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial", Mult Scler, 17, pp.1514~1519 (2011)
21. Canbaz Kabay S, "Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients : 12-months results", Neurourol Urodyn, 36, pp.104~110 (2017)
22. Tudor KI, "Outcomes following percutaneous tibial nerve stimulation(PTNS)treatment for neurogenic and idiopathic overactive bladder", Clin Auton Res, 30, pp.61~67 (2020)
23. Engeler DS, "Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis : a single-centre prospective series", BMC Urol, 15, pp.105~ (2015)
24. Blaivas JG, "Detrusor-external sphincter dyssynergia : a detailed electromyographic study", J Urol, 125, pp.545~548 (1981)
25. Weld KJ, "Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury", Urology, 56, pp.565~568 (2000)
26. Groen J, "Summary of European Association of Urology(EAU)Guidelines on Neuro-Urology", Eur Urol, 69, pp.324~333 (2016)
27. Castro-Diaz D, "Incontinence", pp.865~891 (2002), Health Publication
28. Abrams P, "Tamsulosin : efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury", J Urol, 170(4 Pt 1), pp.1242~1251 (2003)
29. Amarenco G, "First-line urological evaluation in multiple sclerosis : validation of a specific decision-making algorithm", Mult Scler, 19, pp.1931~1937 (2013)
30. De Ridder D, "Consensus guidelines on the neurologist’s role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis", Clin Neurol Neurosurg, 115, pp.2033~2040 (2013)
31. Ghezzi A, "Recommendations for the management of urinary disorders in multiple sclerosis : a consensus of the Italian Multiple Sclerosis Study Group", Neurol Sci, 32, pp.1223~1231 (2011)
32. Chancellor MB, "Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function", J Am Paraplegia Soc, 16, pp.207~214 (1993)
33. Stankovich EIu, "Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis", Urologiia, (4), pp.48~51 (2004)
34. Blok BF, "Ultrastructural evidence for a direct pathway from the pontine micturition center to the parasympathetic preganglionic motoneurons of the bladder of the cat", Neurosci Lett, 222, pp.195~198 (1997)
35. Meythaler JM, "Continuous intrathecal baclofen in spinal cord spasticity. A prospective study", Am J Phys Med Rehabil, 71, pp.321~327 (1992)
36. Bushman W, "Voiding dysfunction in patients with spastic paraplegia : urodynamic evaluation and response to continuous intrathecal baclofen", Neurourol Urodyn, 12, pp.163~170 (1993)
37. Dykstra DD, "Treatment of detrusor-sphincter dyssynergia with botulinum A toxin : a double-blind study", Arch Phys Med Rehabil, 71, pp.24~26 (1990)
38. Schurch B, "Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia : a prospective study in 24 spinal cord injury patients", J Urol, 155, pp.1023~1029 (1996)
39. Mahajan ST, "The prevalence of urinary catheterization in women and men with multiple sclerosis", J Spinal Cord Med, 36, pp.632~637 (2013)
40. Lundberg PO, "Sexual dysfunction in female patients with multiple sclerosis", Int Rehabil Med, 3, pp.32~34 (1981)
41. Zorzon M, "Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups", Mult Scler, 5, pp.418~427 (1999)
42. Balsamo R, "Increased risk of erectile dysfunction in men with multiple sclerosis : an Italian cross-sectional study", Cent European J Urol, 70, pp.289~295 (2017)
43. Feinstein A, "Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression", J Affect Disord, 66, pp.193~198 (2001)
44. Francomano D, "Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction : a pilot study", J Endocrinol Invest, 40, pp.275~279 (2017)
45. Tomé ALF, "Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis", Clinics(Sao Paulo), 74, pp.e713~ (2019)
46. "Prog Urol", 2019, 385~390
47. Lombardi G, "Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature", J Sex Med, 9, pp.970~985 (2012)
48. Fowler CJ, "A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis", J Neurol Neurosurg Psychiatry, 76, pp.700~705 (2005)
49. Safarinejad MR, "Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a doubleblind, placebo controlled, randomized study", J Urol, 181, pp.252~258 (2009)
50. Lombardi G, "Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis", J Sex Med, 7, pp.2192~2200 (2010)
51. Kirkeby HJ, "Pharmacologically induced erection in patients with multiple sclerosis", Scand J Urol Nephrol, 22, pp.241~244 (1988)
52. "Ann Readapt Med Phys", 2001, 35~40
53. Hirsch IH, "Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction", Paraplegia, 32, pp.661~664 (1994)
54. Heller L, "An open trial of vacuum penile tumescence : constriction therapy for neurological impotence", Paraplegia, 30, pp.550~553 (1992)
55. Chéhensse C, "The spinal control of ejaculation revisited : a systematic review and meta-analysis of anejaculation in spinal cord injured patients", Hum Reprod Update, 19, pp.507~526 (2013)
56. Soler JM, "Midodrine improves ejaculation in spinal cord injured men", J Urol, 178, pp.2082~2086 (2007)
57. Safarinejad MR, "Midodrine for the treatment of organic anejaculation but not spinal cord injury : a prospective randomized placebo-controlled double-blind clinical study", Int J Impot Res, 21, pp.213~220 (2009)
58. Fan LC, "Penile vibratory stimulation and electroejaculation in the treatment of ejaculatory dysfunction", Zhonghua Nan Ke Xue, 11, pp.219~222 (2005)
59. Cavalla P, "Fertility in patients with multiple sclerosis : current knowledge and future perspectives", Neurol Sci, 27, pp.231~239 (2006)
60. Bronner G, "Female sexuality in multiple sclerosis : the multidimensional nature of the problem and the intervention", Acta Neurol Scand, 121, pp.289~301 (2010)
61. Hulter BM, "Sexual function in women with advanced multiple sclerosis", J Neurol Neurosurg Psychiatry, 59, pp.83~86 (1995)
62. Lew-Starowicz M, "Prevalence of sexual dysfunctions among women with multiple sclerosis", Sex Disabil, 31, pp.141~153 (2013)
63. Sacco E, "Sexual dysfunctions in patients affected by multiple sclerosis: evaluation in a contemporary cohort from a referral center", Eur Urol Suppl, 10, pp.160~ (2011)[DOI]
64. Merghati-Khoei E, "Sexual problems among women with multiple sclerosis", J Neurol Sci, 331, pp.81~85 (2013)
65. Dachille G, "Sexual dysfunctions in multiple sclerosis", Minerva Urol Nefrol, 60, pp.77~79 (2008)
66. Dasgupta R, "Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis", J Urol, 171, pp.1189~1193 (2004)
67. DasGupta R, "Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies", Drugs, 63, pp.153~166 (2003)
68. Calabrò RS, "Sexual dysfunction in male patients with multiple sclerosis: a need for counseling!", Int J Neurosci, 124, pp.547~557 (2014)
69. Rudick RA, "Health-related quality of life in multiple sclerosis : effects of natalizumab", Ann Neurol, 62, pp.335~346 (2007)
70. Robertson D, "Patient perceived changes in sexual dysfunction after initiation of natalizumab for multiple sclerosis", Mult Scler J Exp Transl Clin, 4, pp.2055217318781989~ (2018)

관련 논문AI추천